Syngene revenue from operations up 17 per cent in Q2FY22
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
More than 90,000 patients utilise the services daily
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
The segment delivered strong sales growth of 20% YoY
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
Domestic business was up 41.9% YoY and 27.7% QoQ
First and only therapy approved by the FDA for the treatment of pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis
Subscribe To Our Newsletter & Stay Updated